5.5 Master the Raw Material Technology to Guarantee Detection Results
At the early stage of development of chemiluminescence in China, many manufacturers have gone through a road of breakthrough of unique items in the market, and of course, the expansion of some items has also provided important value to clinical practice. However, the core competition items in the future market will still be the mainstream detection items. With the continuous improvement of the reagent menu of each mainstream manufacturer, the items and detection technologies will become homogeneous, and it will be hard to achieve the competitive advantages only by virtue of the items in the future. The final consideration for manufacturers must be the detection quality, and the core technology to determine the detection quality will be raw material technology.
In the future, the ability and system of metrological traceability will become important competitive advantages for in vitro diagnostic enterprises. The in vitro diagnostic enterprises with stronger traceability will be more potential for development. With the product quality advantage, they will be recognized by end users, steadily grow in fierce competition, and finally compete with internationally renowned brands in the global market.
